Regorafenib Regulates AD Pathology, Neuroinflammation, and Dendritic Spinogenesis in Cells and a Mouse Model of AD.

Cells · 2020 · PMC7408082 · PMID 32660121

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

iNOS mRNA levels in LPS-treated primary astrocytes showed a decreasing trend in response to regorafenib ( Figure 3 L–P).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.